Reproterol
Top View
- (12) United States Patent (10) Patent No.: US 8.426,475 B2 Weidner Et Al
- 2021 Equine Prohibited Substances List
- Global Strategy for Asthma Management and Prevention Online Appendix
- Section B Changed Classes/Guidelines Final Version Date of Issue
- Supplementary File
- Benefit Assessment of Medicinal Products with New Active
- Inhalation Composition Containing Aclidinium for Treatment of Asthma and Chronic Obstructive Pulmonary Disease
- Amineptine, Amiphenazole, Amphetamines, Bromantan, Caffeine
- Statistical Analysis Plan
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Shelley 2004 Cardiovasc B2ag
- Study Protocols
- TUE Physician Guidelines ASTHMA 1. Medical Condition
- Justification
- (12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
- Inhalation Composition Containing Aclidinium for Treatment of Asthma and Chronic Obstructive Pulmonary Disease
- NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
- Customs Tariff - Schedule Xxi - 1